- Home
- ORKA vs GRRR Comparison
ORKA vs GRRR Comparison
Compare ORKA & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- GRRR
- Stock Information
- Founded
- ORKA 2004
- GRRR 2001
- Country
- ORKA United States
- GRRR United Kingdom
- Employees
- ORKA N/A
- GRRR N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GRRR Computer Software: Prepackaged Software
- Sector
- ORKA Health Care
- GRRR Technology
- Exchange
- ORKA Nasdaq
- GRRR Nasdaq
- Market Cap
- ORKA 354.2M
- GRRR 320.5M
- IPO Year
- ORKA N/A
- GRRR N/A
- Fundamental
- Price
- ORKA $10.96
- GRRR $17.38
- Analyst Decision
- ORKA Strong Buy
- GRRR Buy
- Analyst Count
- ORKA 8
- GRRR 1
- Target Price
- ORKA $39.71
- GRRR $18.00
- AVG Volume (30 Days)
- ORKA 143.0K
- GRRR 1.2M
- Earning Date
- ORKA 05-14-2025
- GRRR 03-31-2025
- Dividend Yield
- ORKA N/A
- GRRR N/A
- EPS Growth
- ORKA N/A
- GRRR N/A
- EPS
- ORKA N/A
- GRRR N/A
- Revenue
- ORKA N/A
- GRRR $74,674,030.00
- Revenue This Year
- ORKA N/A
- GRRR $36.59
- Revenue Next Year
- ORKA N/A
- GRRR $30.68
- P/E Ratio
- ORKA N/A
- GRRR N/A
- Revenue Growth
- ORKA N/A
- GRRR 15.43
- 52 Week Low
- ORKA $5.49
- GRRR $2.09
- 52 Week High
- ORKA $52.32
- GRRR $44.15
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- GRRR 48.78
- Support Level
- ORKA N/A
- GRRR $15.35
- Resistance Level
- ORKA N/A
- GRRR $18.04
- Average True Range (ATR)
- ORKA 0.00
- GRRR 1.40
- MACD
- ORKA 0.00
- GRRR 0.27
- Stochastic Oscillator
- ORKA 0.00
- GRRR 58.33
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.